A Latent Allocation Model for the Analysis of Microbial Composition and Disease
暂无分享,去创建一个
[1] James T. Morton,et al. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome , 2017, Movement disorders : official journal of the Movement Disorder Society.
[2] Naonori Ueda,et al. Deterministic Annealing Variant of the EM Algorithm , 1994, NIPS.
[3] G. Deuschl,et al. Gut microbiota in Parkinson disease in a northern German cohort , 2017, Brain Research.
[4] J Paul Brooks,et al. Challenges for case-control studies with microbiome data. , 2016, Annals of epidemiology.
[5] M. Pop,et al. Robust methods for differential abundance analysis in marker gene surveys , 2013, Nature Methods.
[6] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[7] A. Heintz‐Buschart,et al. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder , 2017, Movement disorders : official journal of the Movement Disorder Society.
[8] Hongzhe Li,et al. A two-part mixed-effects model for analyzing longitudinal microbiome compositional data , 2016, Bioinform..
[9] I. Saltykova,et al. Analysis of Gut Microbiota in Patients with Parkinson’s Disease , 2017, Bulletin of Experimental Biology and Medicine.
[10] Hongzhe Li,et al. A Logistic Normal Multinomial Regression Model for Microbiome Compositional Data Analysis , 2013, Biometrics.